NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting
TOKYO, Nov 7, 2024 - (JCN Newswire) - Utilizing proprietary generative AI technology, NEC Bio has successfully modified T cell